S. R. Schill & Associates increased its position in shares of HealthSouth Corporation (NYSE:HLS) by 9.6% during the second quarter, Holdings Channel reports. The firm owned 8,428 shares of the company’s stock after buying an additional 740 shares during the period. S. R. Schill & Associates’ holdings in HealthSouth Corporation were worth $408,000 at the end of the most recent quarter.

Several other hedge funds also recently made changes to their positions in HLS. Wellington Management Group LLP boosted its stake in shares of HealthSouth Corporation by 4,377.7% in the first quarter. Wellington Management Group LLP now owns 995,082 shares of the company’s stock worth $42,599,000 after buying an additional 972,859 shares during the period. Mackay Shields LLC bought a new stake in shares of HealthSouth Corporation during the second quarter worth approximately $39,641,000. Deprince Race & Zollo Inc. bought a new stake in shares of HealthSouth Corporation during the first quarter worth approximately $16,129,000. Renaissance Technologies LLC boosted its stake in shares of HealthSouth Corporation by 83.6% in the first quarter. Renaissance Technologies LLC now owns 710,200 shares of the company’s stock worth $30,404,000 after buying an additional 323,300 shares during the period. Finally, Vanguard Group Inc. boosted its stake in shares of HealthSouth Corporation by 4.6% in the first quarter. Vanguard Group Inc. now owns 7,204,375 shares of the company’s stock worth $308,419,000 after buying an additional 318,619 shares during the period. 97.96% of the stock is owned by institutional investors.

Shares of HealthSouth Corporation (HLS) opened at 43.82 on Friday. The company’s 50-day moving average price is $45.57 and its 200-day moving average price is $44.19. HealthSouth Corporation has a 1-year low of $36.97 and a 1-year high of $49.71. The company has a market capitalization of $4.33 billion, a PE ratio of 15.97 and a beta of 0.61.

HealthSouth Corporation (NYSE:HLS) last issued its quarterly earnings results on Monday, July 31st. The company reported $0.71 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.68 by $0.03. HealthSouth Corporation had a return on equity of 25.07% and a net margin of 6.70%. The firm had revenue of $981.30 million for the quarter, compared to analyst estimates of $976.46 million. During the same period in the previous year, the firm earned $0.69 earnings per share. The company’s revenue was up 6.6% compared to the same quarter last year. On average, equities analysts expect that HealthSouth Corporation will post $2.71 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Monday, October 16th. Shareholders of record on Monday, October 2nd will be paid a $0.25 dividend. The ex-dividend date is Friday, September 29th. This is a positive change from HealthSouth Corporation’s previous quarterly dividend of $0.24. This represents a $1.00 annualized dividend and a yield of 2.28%. HealthSouth Corporation’s payout ratio is 35.29%.

COPYRIGHT VIOLATION WARNING: “HealthSouth Corporation (NYSE:HLS) Position Boosted by S. R. Schill & Associates” was reported by Daily Political and is the property of of Daily Political. If you are accessing this article on another publication, it was copied illegally and republished in violation of US and international copyright and trademark legislation. The legal version of this article can be viewed at https://www.dailypolitical.com/2017/08/13/healthsouth-corporation-nysehls-position-boosted-by-s-r-schill-associates.html.

A number of analysts have recently commented on HLS shares. Zacks Investment Research cut HealthSouth Corporation from a “hold” rating to a “sell” rating in a research note on Tuesday, April 25th. Barclays PLC reaffirmed an “underweight” rating and issued a $46.00 price target (up from $44.00) on shares of HealthSouth Corporation in a research note on Monday, May 1st. ValuEngine cut HealthSouth Corporation from a “buy” rating to a “hold” rating in a research note on Friday, June 2nd. BidaskClub cut HealthSouth Corporation from a “hold” rating to a “sell” rating in a research note on Thursday, July 13th. Finally, KeyCorp started coverage on HealthSouth Corporation in a research note on Thursday, June 15th. They issued a “sector weight” rating for the company. Two analysts have rated the stock with a sell rating, three have issued a hold rating and seven have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and an average price target of $48.83.

In other HealthSouth Corporation news, CEO Mark J. Tarr sold 22,625 shares of the business’s stock in a transaction that occurred on Thursday, August 3rd. The stock was sold at an average price of $42.55, for a total value of $962,693.75. Following the transaction, the chief executive officer now directly owns 283,134 shares of the company’s stock, valued at $12,047,351.70. The sale was disclosed in a legal filing with the SEC, which is available through this link. 1.60% of the stock is currently owned by insiders.

About HealthSouth Corporation

HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company manages its operations through segments, including inpatient rehabilitation, and home health and hospice.

Want to see what other hedge funds are holding HLS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthSouth Corporation (NYSE:HLS).

Institutional Ownership by Quarter for HealthSouth Corporation (NYSE:HLS)

Receive News & Ratings for HealthSouth Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthSouth Corporation and related companies with MarketBeat.com's FREE daily email newsletter.